Clinical Characteristics, Management, and Outcomes of Colitis-Associated Colorectal Cancer and the Comparison With Sporadic Colorectal Cancer in Taiwan.
Journal
Clinical and translational gastroenterology
Journal Volume
16
Journal Issue
2
Pages
e00798
ISSN
2155-384X
Date Issued
2025-02-01
Author(s)
Wu, Hsin-Yun
Chou, Jen-Wei
Yen, Hsu-Heng
Lin, Chun-Chi
Chiang, Feng-Fan
Chung, Chen-Shuan
Lin, Wei-Chen
Chang, Chen-Wang
Le, Puo-Hsien
Kuo, Chia-Jung
Lin, Ching-Pin
Hsu, Wen-Hung
Chuang, Chiao-Hsiung
Tsai, Tzung-Jiun
Feng, I-Che
Huang, Tien-Yu
Abstract
Ulcerative colitis (UC) is a chronic inflammation of the gastrointestinal tract and is characterized by alternating periods of inflammation and remission. Although UC incidence is lower in Taiwan than in Western countries, its impact remains considerable, demanding updated guidelines for addressing local healthcare challenges and patient needs. The revised guidelines employ international standards and recent research, emphasizing practical implementation within the Taiwanese healthcare system. Since the inception of the guidelines in 2017, the Taiwan Society of Inflammatory Bowel Disease has acknowledged the need for ongoing revisions to incorporate emerging therapeutic options and evolving disease management practices. This updated guideline aims to align UC management with local contexts, ensuring comprehensive and context-specific recommendations, thereby raising the standard of care for UC patients in Taiwan. By adapting and optimizing international protocols for local relevance, these efforts seek to enhance health outcomes for patients with UC. © 2024 Korean Association for the Study of Intestinal Diseases. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Type
journal article